Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme
<p style="text-align:justify;"> <b>Background:</b> Bowel cancer is common and a major cause of death. The NHS is currently rolling out a national bowel cancer screening programme that aims to cover the entire population by 2010. The programme will be based on the Faecal...
Main Authors: | Wilson, S, Taskila, T, Ismail, T, Stocken, D, Martin, A, Redman, V, Wakelam, M, Perry, I, Hobbs, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2009
|
Similar Items
-
Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme
by: Wakelam Michael, et al.
Published: (2009-01-01) -
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population.
by: Wilson, S, et al.
Published: (2006) -
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population
by: Wilson, S, et al.
Published: (2006) -
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population
by: Colbourne Lynne, et al.
Published: (2006-10-01) -
Serum matrix metalloproteinase 9 and colorectal neoplasia: a community-based evaluation of a potential diagnostic test.
by: Wilson, S, et al.
Published: (2012)